PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns

2025-10-20
(Press-News.org) In a recent study published today in the European Geosciences Union (EGU) journal Biogeosciences, scientists have confirmed that mercury pollution from artisanal and small-scale gold mining (ASGM) is contaminating food crops not through the soil, as previously believed, but directly from the air. Driven by the surging price of gold, which has increased by more than tenfold since 2000, the rapid expansion of unregulated mining in these regions raises urgent questions about food security, human health, and environmental justice

The study, conducted by an international team of scientists led by Excellent O. Eboigbe and David McLagan at Queens University, and Abiodun Odukoya Mary at the University of Lagos, focused on a farming community in Nigeria situated near an artisanal and small-scale gold mining site. The researchers compared crops from a field located 500 meters from the ASGM site with those grown 8 kilometres away. The contrast was striking mercury concentrations in leaves and grains were approximately 10-50 times higher in the farm closer to the mining site.

For decades, scientists have assumed that mercury enters food crops primarily via the roots, after leaching into the soil or water. But this new research, using sophisticated mercury stable isotope analyses, reveals a very different mechanism at work. Most of the mercury found in plant tissues came from the atmosphere, taken up through leaves during photosynthesis. In short: plants are breathing in mercury. David McLagan states that: 

“Mercury uptake by plants from air represents the largest sink of mercury from air to terrestrial [land and freshwater] systems. While this critical ecosystem service helps reduce the amount of mercury being globally redistributed through the atmosphere, it raises human health concerns when it is staple crops that are the mechanism stripping the air of mercury.”  

The research team found that leafy plant parts, which are often consumed by humans and livestock, retained the highest mercury concentrations. Edible, non-leafy parts of the plants, like cassava roots or maize kernels, had lower concentrations yet still showed significant contamination. While levels remained below international mercury consumption thresholds, the authors warn that there could still be health concerns when consuming mercury contaminated crops near ASGM sites, as international standards employed conservative crop consumption rates, and that even greater contamination of air, soils, and crops have been observed in other studies. This is especially relevant in communities dependent on local agriculture for survival.

Used to extract gold from raw ore, Mercury is a powerful neurotoxin. Long-term exposure, even at low levels, can damage the nervous system, impair cognitive development in children, and cause serious cardiovascular and reproductive problems. Due to its frequent use in artisanal and small-scale mining operations, vulnerable populations in low-income rural areas are at higher risk.

" Miners will not stop using mercury for gold extraction unless they get a readily available alternative that is also cost-effective.” Said Odukoya Abiodun Mary

ASGM is now the largest source of mercury emissions globally, according to the UN Environment Programme. Yet regulation and monitoring are limited in many parts of the Global South, where ASGM is often an economic lifeline for communities facing poverty and displacement. This study pushes a critical but overlooked consequence of that boom to the forefront: food systems are being contaminated, quietly and invisibly, by elevated levels of mercury in the air.

The research is also a call to action for governments and international organizations tasked with enforcing the ‘Minamata Convention on Mercury’. Current monitoring strategies focus largely on water bodies, sediment, and seafood, not crops. This study shows those efforts are missing a key vector of exposure.

“Due to the toxicity of bioaccumulation and biomagnification potential of methylmercury, fish consumption in ASGM areas has been a major focus of epidemiological research in ASGM areas. Yet this work demonstrates that there are other dietary sources of mercury, and mercury from these different sources can have cumulative effects.” 

The study concludes that new policies are urgently needed to monitor and mitigate airborne mercury exposure in agricultural regions near mining activities. Considering the rapid growth of artisanal and small-scale gold mining, millions of people across Africa, South America, and Asia may be facing long-term health risks from something as simple and essential as growing and consuming local foods.

Press contact:
Media and Engagement Manager Asmae Ourkiya    
European Geosciences Union
Email: media@egu.eu


About the EGU

The European Geosciences Union (EGU) is Europe’s premier geosciences union, dedicated to the pursuit of excellence in the Earth, planetary, and space sciences for the benefit of humanity, worldwide. It is a non-profit interdisciplinary learned association of scientists founded in 2002 with headquarters in Munich, Germany. The EGU publishes a number of diverse scientific journals that use an innovative open access format and organises topical meetings plus education and outreach activities. Its annual General Assembly is the largest and most prominent European geosciences event, attracting more than 20,000 scientists from all over the world. The meeting’s sessions cover a wide range of topics, including volcanology, planetary exploration, the Earth’s internal structure and atmosphere, climate, energy, and resources.

If you wish to receive our press releases via email, please use the Press Release Subscription Form at https://www.egu.eu/news/subscription/. Subscribed journalists and other members of the media receive EGU press releases under embargo (if applicable) 24 hours in advance of public dissemination.

END


ELSE PRESS RELEASES FROM THIS DATE:

Nearly half of Finns with chronic conditions find medication therapy a burden

2025-10-20
According to a recent study, 44% of people with chronic conditions who responded to a population-based survey experienced medication-related burden (MRB). The burden was most common among people with diabetes, heart disease, rheumatic disease or some other musculoskeletal disorder. The greatest burden was caused by factors associated with health care, such as fragmented care and the cost of medicines, as well as adverse drug reactions or concerns about them.  “Other factors linked with MRB were poor health status, limits on functional capacity and low income,” says Pharmacist and Doctoral Researcher Heidi Mikkola from the School of Pharmacy at the University of ...

Do animals fall for optical illusions? What fish and birds can teach us about perception

2025-10-20
Have you ever looked at two circles of exactly the same size and sworn one was larger? If so, your eyes have been tricked by the Ebbinghaus illusion, a classic example of how context can shape what we see. Place a circle among other smaller circles, and it seems bigger; place it among larger ones, and it shrinks before our eyes. This illusion fascinates psychologists because it reveals that perception is not a mirror of the outside world but a clever construction of the brain. But here is the question that inspired our study: do other animals fall for the same tricks? If a tiny fish or a bird perceives ...

New guideline emphasizes conversations about mood, mental health between patients and clinicians

2025-10-20
Depression is a mental illness, and support for depression can improve emotions, thoughts, and well-being. A new guideline from the Canadian Task Force on Preventive Health Care recommends that patients aged 18 and older talk to their health care providers about depression rather than undergo routine screening with standard tools, like questionnaires. The guideline is published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250237. In Canada, depression is common, with about 1 in 10 people (without bipolar disorder) experiencing depression in their lifetimes. It negatively affects how a person ...

Children’s Hospital of Philadelphia researchers observe significant reduction in diagnosis of food allergies following expert guidelines encouraging early peanut exposure

2025-10-20
Philadelphia, October 20, 2025 – Peanuts represent one of the most common causes of immunoglobulin E (IgE)-mediated, or anaphylactic, food allergies in children, yet a landmark study found that early introduction of peanut to infants may lower their risk of developing this allergy. Now, a new study from researchers from Children’s Hospital of Philadelphia (CHOP) has shown that the rates of diagnosis of peanut and other IgE-mediated food allergies have declined since the adoption of guidelines encouraging early introduction practices. The findings, published today ...

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

2025-10-19
VT3989 is a first-in-class YAP-TEAD inhibitor from Vivace Therapeutics that is currently in Phase I/II trials for patients with advanced solid tumors, with a focus on refractory mesothelioma In this trial, VT3989 demonstrated notable antitumor activity, with a disease control rate of 86% at the clinically optimized dosing levels These data provide the first clinical proof-of-concept for effectively drugging the Hippo-YAP-TEAD pathway VT3989 was awarded Orphan Drug Designation and Fast Track Designation for the treatment of mesothelioma by the FDA BERLIN, OCTOBER 19, 2025 ― The first-in-class YAP-TEAD inhibitor ...

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

2025-10-19
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found. The observation by researchers at the University of Florida and the University of Texas MD Anderson Cancer Center is a defining moment in a decade-plus of research testing mRNA-based therapeutics designed to “wake up” the immune system against cancer. Building on a previous UF study, the observation also marks a significant step toward a long-awaited universal cancer vaccine to ...

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy

2025-10-19
Cancer patients who received mRNA COVID vaccines within 100 days of starting immunotherapy were twice as likely to be alive three years after treatment as those who never received a vaccine These findings have prompted a randomized Phase III trial to determine if mRNA COVID vaccines should be part of the standard of care for this type of therapy If validated, findings could significantly increase the number of patients who benefit from immunotherapy BERLIN, OCTOBER 19, 2025 ― Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning ...

Drug combo cuts risk of death in advanced prostate cancer by 40%

2025-10-19
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The combination therapy, which adds a drug called enzalutamide to commonly prescribed hormone therapy, reduced deaths in patients with recurrent prostate cancer after surgery or radiation for whom other treatments are no longer an option. The trial results were published in The New England Journal of Medicine (NEJM) with simultaneous presentation during the European Society for Medical Oncology Congress (ESMO) Oct. 19 in Berlin. “After ...

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

2025-10-19
BERLIN October 19, 2025 – Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan compared to standard chemotherapy. These findings, which stem from the ASCENT-03 trial in triple-negative breast cancer co-led by investigators at Dana-Farber Cancer Institute, are presented today at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. They are also published simultaneously in the New England Journal ...

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

2025-10-18
BERLIN October 18, 2025 – Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation selective estrogen receptor degrader and full antagonist, compared to a standard combination approach. These findings, from the phase 3 evERA Breast Cancer study, are presented today by Dr. Erica Mayer of Dana-Farber Cancer Institute at the annual meeting of the European Society for Medical Oncology (ESMO) in Berlin, Germany. Tumors that express the estrogen receptor (ER) account for roughly 70% ...

LAST 30 PRESS RELEASES:

Combination therapy could expand treatment options for AML patients, extend survival

Microscopic DNA ‘flowers’ could deliver medicine exactly where it’s needed

Hormone therapy alters body proteins to match gender identity

Eat, explore, rest: a leptin-sensing brain circuit helps overcome anxiety to meet vital needs

2D devices have hidden cavities that can modify electronic behavior

Experts urge risk-based monitoring as Barrett’s esophagus care moves beyond one-size-fits-all

How multiple sclerosis harms a brain long before symptoms appear

Did marine life in the palaeocene use a compass?

About 9 in 10 haven’t heard of condition that affects nearly 90% of U.S. adults

Personalized brain stimulation offers new hope for people with hard-to-treat epilepsy

The tiny droplets that bounce without bursting

Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

What is the extent of disparities in cancer clinical trials among low- and middle-income countries?

Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns

Nearly half of Finns with chronic conditions find medication therapy a burden

Do animals fall for optical illusions? What fish and birds can teach us about perception

New guideline emphasizes conversations about mood, mental health between patients and clinicians

Children’s Hospital of Philadelphia researchers observe significant reduction in diagnosis of food allergies following expert guidelines encouraging early peanut exposure

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy

Drug combo cuts risk of death in advanced prostate cancer by 40%

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

[Press-News.org] Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns